Back to Journals » Therapeutics and Clinical Risk Management » Volume 13

Original Research

Real-world use of PCSK-9 inhibitors by early adopters: cardiovascular risk factors, statin co-treatment, and short-term adherence in routine clinical practice

       
Total article views   HTML views PDF downloads Totals
11,887 Dovepress* 10,070+ 1,567 11,637
PubMed Central* 1,817 492 2,309
Totals 11,887 2,059 13,946
*Since 3 August 2017

View citations on PubMed Central and Google Scholar